MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dysarthria"

  • 2019 International Congress

    Clear versus conversational speech in Parkinson’s disease, progressive supranuclear palsy, and multiple system atrophy

    T. Tykalova, D. Skrabal, J. Klempir, E. Ruzicka, J. Rusz (Prague, Czech Republic)

    Objective: This study aimed to investigate the speech behavior of PD, MSA, and PSP in clear vs. conversational speech task compared to healthy controls (HC).…
  • 2019 International Congress

    Lip movement contribution in speech production of persons with Parkinson’s Disease

    P. Upadhyay, S. Gudwani, K. Sharma, R. Sagar, R. Dhamija, S. Kumaran (New Delhi, India)

    Objective: Lip movements contribute to communication by producing labial sounds, conveying facial expression and aiding visually in speech perception. This study planned to understand lip-movements…
  • 2019 International Congress

    “Best practice” guidelines for the collection and analysis of speech data in patients with Parkinson’s Disease (PD).

    E. Tripoliti, L. Ramig (Boulder Colorado, CO, USA)

    Objective: To discuss the literature for collection and analysis of speech data for patients with PD in order to create “best practice” guidelines. Background: Speech…
  • 2019 International Congress

    Influence of cognitive abilities on prominence production in mild dysarthric patients with Parkinson’s disease

    T. Thies, D. Mücke, A. Lowit, J. Steffen, E. Kalbe, M. Barbe (Cologne, Germany)

    Objective: This study investigates prominence marking (highlighting of prominent elements by adjusting speech parameters in the glottal, supraglottal and subglottal systems) and how this ability…
  • 2019 International Congress

    The origin of stimulation-induced dysarthria in ET patients after VIM/PSA-DBS: Atactic, spastic or both?

    H. Jergas, J. Petry-Schmelzer, J. Becker, T. Thies, J. Steffen, V. Visser-Vandewalle, T. Dembek, M. Barbe (Cologne, Germany)

    Objective: To investigate the origin of stimulation-induced dysarthria (SID) in essential tremor (ET) patients with bilateral deep brain stimulation (DBS) in the ventral intermediate nucleus…
  • 2019 International Congress

    Unclear Pronunciation of Stop Consonant Sounds in Patients with Parkinson’s Disease Following Deep Brain Stimulation

    T. Sakurai, T. Yamamoto, Y. Yamanaka, S. Hirano, M. Abe, Y. Uji, A. Murata, Y. Higuchi, S. Kuwabara (Chiba-Ken, Japan)

    Objective: To clarify the characteristics of changes in stop consonant articulation in PD subjects before and after DBS and compared with control group by using…
  • 2019 International Congress

    Differential effects of stimulation amplitude and lead laterality of deep brain stimulation of the subthalamic nucleus on speech and Parkinsonian motor symptoms

    E. Tripoliti, B. Veggia, M. Hariz, P. Limousin (Reggio Emili, Italy)

    Objective: To examine the differential effects of subthalamic nucleus deep brain stimulation (STN DBS) amplitude (high and low) and lead laterality (Left-Right-bilateral) on speech intelligibility…
  • 2019 International Congress

    Stability and reliability of objective measures of speech in Parkinson’s Disease over 12 months

    M. Magee, J. Tamplin, C. Marigliani, F. Baker, M. Morris, A. Vogel (Melbourne, Australia)

    Objective: To describe the stability and reliability of acoustic measures of speech in Parkinson’s Disease (PD) at 3 and 12 months. Background: Speech biomarkers hold…
  • 2019 International Congress

    Global implementation of efficacious voice treatment for Parkinson’s disease: LSVT LOUD in Germany, France and Japan

    L. Ramig, T. Brauer, C. Airiau, M. Fujiu-Kurachi (Boulder, CO, USA)

    Objective: This study was designed to evaluate the implementation of an efficacious voice treatment, Lee Silverman Voice Treatment (LSVT LOUD), into scope of clinical practice…
  • 2018 International Congress

    Intraparenchymal Cyst Formation: A Rare Complication of Deep Brain Stimulation

    K. Tan, C. Zadikoff (Chicago, IL, USA)

    Objective: Intraparenchymal cyst formation after Deep Brain Stimulation (DBS) surgery is a rare complication. There are only 8 cases reported in the literature. We report…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 16
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley